Microdosing psychedelics is the practice of consuming mushrooms containing very low, sub-hallucinogenic doses of a psychedelic substance, such as lysergic acid diethylamide (LSD) or psilocybin.
According to media reports, Micro dose has increased in popularity, yet scientific literature includes minimal research on the practice. There has been limited reporting on adverse events associated with Microdosing, and microdoses experiences have not been classified in community samples.
Image Source: Google
Our growing inventory has everything from seriously fresh magic mushrooms and the best Microdose of psilocybe mushrooms.
The practice of Microdosing psychedelics involves the induction of sub-hallucinogen amounts of a psychedelic substance (eg LSD, psilocybin) and has recently increased in popularity.
The number of popular media accounts and book-length treatments of Microdosing has been growing. Microdosing psychoacoustic substances: demography, psychometric comorbidity, and comorbid substance use in the preparation and future directions are unclear.
While full-dose psychedelic research is gaining prominence and results from full-dose studies can certainly inform. Microdosing studies, focusing only on full-dose results may have specific unexpected benefits and challenges for Microdosing.
As such, beginning with an open, exploratory approach can provide a better understanding of the potential benefits and specific challenges for Microdosing.
The current study aims to provide a data-driven classification describing the positive and negative experiences derived from an open-ended analysis of micro-specific results by micro dispersed.